New York Life Invts Active E (MMCA): which funds own it
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
Sections with a free account
No concentrated manager holds it.
Quarter flow (concentrated managers)
Concentrated managers holding it
None in the latest quarter.
Largest holders of MMCA (all 13F filers)
- New York Life Investment Management3.3 MType not verified+2.8 M
- Wealth Enhancement Advisory Services478 KWealth adviser+310 K
- Weil436 KType not verified+4,920
- Cetera Investment Advisers157 KWealth adviser+31 K
- Octavia Wealth Advisors99 KWealth adviser−30 K
- Cambridge Investment Research Advisors84 KWealth adviser+25 K
- Brio Consultants75 KType not verified+13 K
- Guggenheim Capital35 KType not verified+35 K
- Entruity Wealth33 KWealth adviser−81 K
- Avantax Planning Partners29 KType not verified+2,016
- Shares
- 3.3 M
- Change
- +2.8 M
See more
- Type
- Type not verified
- Value
- $71.3M
- Shares
- 478 K
- Change
- +310 K
See more
- Type
- Wealth adviser
- Value
- $10.4M
- Weil
- Shares
- 436 K
- Change
- +4,920
See more
- Type
- Type not verified
- Value
- $9.5M
- Shares
- 157 K
- Change
- +31 K
See more
- Type
- Wealth adviser
- Value
- $3.4M
- Shares
- 99 K
- Change
- −30 K
See more
- Type
- Wealth adviser
- Value
- $2.2M
- Shares
- 84 K
- Change
- +25 K
See more
- Type
- Wealth adviser
- Value
- $1.8M
- Brio Consultants
- Shares
- 75 K
- Change
- +13 K
See more
- Type
- Type not verified
- Value
- $1.6M
- Shares
- 35 K
- Change
- +35 K
See more
- Type
- Type not verified
- Value
- $756K
- Entruity Wealth
- Shares
- 33 K
- Change
- −81 K
See more
- Type
- Wealth adviser
- Value
- $716K
- Shares
- 29 K
- Change
- +2,016
See more
- Type
- Type not verified
- Value
- $640K
The 10 13F filers with the most shares as of Jun 30, 2026, whatever their type (index firms usually come first). “Change”: shares added or cut versus the previous quarter, split-adjusted; “no data” = there is no comparable portfolio for the previous quarter (no filing, or a filing with its holdings under confidential treatment). “% of the company” only where shares outstanding are up to date. Entities of the same group file separately and some 13F filings include other managers: there may be double counting. With a free account: the top 25, the largest buyers and the largest sellers.
Insiders (Form 4)
Open-market purchases, excluding 10b5-1 plans. Officers and directors only; joint filers of the same purchase count as one. 10% owners with no role are shown separately. 0 = nobody bought; “no data” = we do not have its Form 4 filings.
Each of the company's Form 4 filings, on EDGAR ↗Latest trades, with date and filing →
Above 5% (13D/13G)
Disclosed stakes, with their amendments. A filing is not always a purchase: there are also reductions and changes of filing entity.
This list may be incomplete: we hold 13D and 13G filings made since Dec 23, 2024. A holder above 5% that has not filed anything since then is not shown here.
Above 5% over time (13D/13G)
Each holder with its filings in order. History since December 2024.
This company filed no 8-K forms in the last year. Foreign companies listed in the US (ADRs) report material events on forms 6-K and 20-F, and ETFs and funds do not file 8-Ks. If it is a foreign company listed in the US through ADRs (American Depositary Receipts), what trades are bank-issued certificates that represent shares from its home market. See its filings on EDGAR ↗